Brainzcompany Co., Ltd. Expands Supply of IT Integrated Management Solutions Amid the Spread of AI and Cloud Technologies
Expanded Adoption of Zenius EMS in the Public, Financial, and Manufacturing Sectors
Responding to Growing Demand for Integrated Management of AI and Cloud Infrastructure
[E-Daily Reporter Hyera Lee ] Brains Company ( Brainzcompany Co., Ltd.(099390)), a company specializing in integrated management software for intelligent IT infrastructure, announced on the 15th that it is expanding the supply of its IT operations management solution, "Zenius EMS," in line with the growing adoption of AI and cloud infrastructure. Brainzcompany Co., Ltd. CI. (Photo courtesy of Brainzcompany Co., Ltd.) As the proliferation of AI services leads to growing demand for the integrated management of increasingly complex IT infrastructures—including GPUs, Kubernetes, and the cloud—the company is strengthening its market strategy centered on Zenius EMS, which enables the integrated monitoring of servers, networks, databases (DBs), and applications. Zenius EMS provides integrated management capabilities spanning both on-premises and cloud environments and supports the establishment of operational systems tailored to customer environments through more than 25 point solutions. In the public sector, Brainzcompany Co., Ltd. has supplied its solutions to Gunsan City, the Seoul Immigration and Foreigners’ Affairs Office, and the Chungnam Provincial Office of Education’s Curriculum Evaluation and Information Institute. In the financial and private sectors, it provides EMS-based integrated monitoring solutions to KB Fund Partners, Asung Daiso, and Park Systems Corp. Existing customers, such as Korea Fund Intermediary and the Korea Institute of Ocean Science and Technology, are also continuing to request upgrades and expansions. Seo Eun-sook, a division head at Brainzcompany Co., Ltd., stated, “Demand for integrated IT infrastructure management is growing due to the spread of AI and cloud computing,” adding, “We will continue to expand our supply in both the public and private markets by leveraging the advanced AI Agent features and our product competitiveness.”
The Financial Supervisory Service (FSS) has launched a surprise on-site investigation into the three major domestic credit rating agencies in connection with the series of defaults by JR GLOBAL REIT a…
SamilPharmaceutical(000520)With “Lorecivivint,” a new drug for osteoarthritis for which BioSplice holds exclusive domestic distribution rights, entering the regulatory review process in the UK followi…
BukwangPharmaceutical(003000)announced on the 11th that it was selected as a “2026 Korea’s Top Job-Creating Company” by the Ministry of Employment and Labor and received a certificate of recognition i…